Skip to content

Public FDA record

Z-0703-03: Glitter Eyes (tefilcon), daily wear soft (hydrophilic) contact lenses packed as single units or kits in m

Recall record Z-0703-03 for Ciba Vision Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0703-03
Company in FDA record
Ciba Vision Corporation
FDA classification date
Apr 1, 2003
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The lens may partially 'delaminate' in the area of one of the encapsulated cosmetic prints.

Source facts

Action
The recall is being conducted to the wholesale level. The firm began contacting consignees via traceable mail on/about 3/17/2003. Included was A Business Reply Form and pre-paid airbill to return the product currently in inventory and the completed form. All inventory and returned product will be destroyed.
Initiated
2003-03-17
Root cause
Other
Terminated
2004-04-07
Distribution
Nationwide, Canada and Puerto Rico.
Recall number
Z-0703-03
Recall status
Terminated
CDRH record ID
26487
FDA classified
2003-04-01
Recall event number
25796

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗